GSKCONS

GSKCONS: Members of the Exchange are hereby informed that the trading in Equity Shares of GlaxoSmithKline Consumer Healthcare Limited shall be suspended w.e.f. April 16, 2020 (i.e. closing hours of trading on April 15, 2020) on account of Scheme of Amalgamation with Hindustan Unilever Limited.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Intimation of Record Date and Effective Date for Scheme of Amalgamation by way of merger by absorption among GlaxoSmithKline Consumer Healthcare Limited and Hindustan Unilever Limited and their respective shareholders and creditors.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange about Scheme of Arrangement

Update on Scheme of amalgamation and arrangement between GlaxoSmithKline Consumer Healthcare Limited and Hindustan Unilever Limited and their respective shareholders and creditors

GlaxoSmithKline Consumer Healthcare Limited has submitted to the Exchange, the financial results for the period ended December 31, 2019.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Board meeting held on February 06, 2020.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Registrar & Share Transfer Agent Update

GlaxoSmithKline Consumer Healthcare Limited has submitted to the Exchange Related Party Transactions, drawn in accordance with applicable accounting standards.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Board meeting held on November 07, 2019.

GlaxoSmithKline Consumer Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2019.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding 'Voting Results and Scrutinizer s Report of Postal Ballot'.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Resignation of Mr Vivek Anand as Executive Director of the company w.e.f. September 27, 2019.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Notice of Postal Ballot

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Notice of Postal Ballot

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Cessation of Mr Kunal Kashyap as Independent Director of the company w.e.f. August 02, 2019.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Cessation of Mr Naresh Dayal as Independent Director of the company w.e.f. August 02, 2019.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Reappointment of Director of the company.

GlaxoSmithKline Consumer Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 02, 2019. Further, the company has informed the Exchange regarding voting results.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 02, 2019

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Board meeting held on August 01, 2019.

GlaxoSmithKline Consumer Healthcare Limited has submitted to the Exchange, the financial results for the period ended June 30, 2019.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that Register of Members and Share Transfer Book of the Company will remain closed from Saturday, July 27, 2019 to Friday, August 2, 2019 (both days inclusive) for the purpose of 60th Annual General Meeting and for taking on record the Shareholders for the purpose of payment of Dividend, if approved at the Annual General Meeting, for the year ended March 31, 2019.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Company has fixed Book Closure from July 27, 2019 to August 2, 2019 for the purpose of AGM and Dividend

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Submission of Half Yearly Disclosure on Related Party Transactions.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

We hereby submit the revised scrutinizer��s report in relation to the business transacted through (i) postal ballot; (ii) e-voting process; and (iii) polling paper at the venue of the meeting of the equity shareholders of GlaxoSmithKline Consumer Healthcare Limited (��Company��) convened and held on Saturday, June 1, 2019 at 12:00 Noon at Punjab Public School Auditorium, The Punjab Public School (Senior Wing), Nabha �� 147201, Punjab pursuant to an order dated April 12, 2019 in Company Application No. CA (CAA) No. 4/Chd/Pb/2019, passed by the Hon��ble Chandigarh bench of the National Company L

GlaxoSmithKline Consumer Healthcare Limited has submitted the Exchange a copy Srutinizers report of Court Convened General Meeting held on Jun 01, 2019. Further, the company has informed the Exchange regarding voting results.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company will remain closed from July 27, 2019 to August 2, 2019, (both days inclusive) for the purpose of Dividend and Annual General Meeting.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on May 10, 2019.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Change in Director(s) of the company.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that Board of Directors at its meeting held on May 10, 2019, recommended Final Dividend of Rs. 105 per equity share.

GlaxoSmithKline Consumer Healthcare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2019.

The Promoter along with PAC has submitted to the Exchange a copy of Annual Disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011 as on March 31, 2019

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding 'Intimation of newspaper publications with respect to the advertisement of notices of Tribunal convened Meetings of the Equity Shareholders and Unsecured Creditors of GlaxoSmithKline Consumer Healthcare Limited'.Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that pursuant to an order dated April 12, 2019 under Section 230(1) of the Companies Act, 2013 (��Act��) in Company Application No. CA (CAA) No. 4/Chd/Pb/2019, passed by the Chandigar

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange about Amalgamation/Merger Notice of Tribunal Convened Meeting of Unsecured Creditors of GlaxoSmithKline Consumer Healthcare Limited

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on Jun 01, 2019Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that pursuant to an order dated April 12, 2019 under Section 230(1) of the Companies Act, 2013 in Company Application No. CA (CAA) No. 4/Chd/Pb/2019, passed by the Chandigarh Bench of the Hon'ble National Company Law Tribunal at Chandigarh ("Tribunal"), a meeting of the equity shareholders of GlaxoSmithKline Consumer Healthca

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on Jun 01, 2019 - Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that pursuant to an order dated April 12, 2019 under Section 230(1) of the Companies Act, 2013 in Company Application No. CA (CAA) No. 4/Chd/Pb/2019, passed by the Chandigarh Bench of the Hon'ble National Company Law Tribunal at Chandigarh ("Tribunal"), a meeting of the equity shareholders of GlaxoSmithKline Consumer Healt

GlaxoSmithKline Consumer Healthcare Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.

The Promoter has submitted to the Exchange a copy of Annual Disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011 as on March 31, 2019.

The Exchange had sought clarification from the Company with respect to news item captioned- "Maharashtra FDA notice for Colgate brand Sensodyne for misleading consumers". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company are aware of any information that has not been announc

��The Exchange has sought clarification from the Company with respect to news item captioned- "Maharashtra FDA notice for Colgate brand Sensodyne for misleading consumers". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company are aware of any information that has not been annou

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Notice of Postal Ballot

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

GlaxoSmithKline Consumer Healthcare Limited has submitted to the Exchange, the financial results for the period ended December 31, 2018.